Related Content
Learn more
poster
Tumour immunity signatures to expand current diagnostic approaches in mismatch repair deficient cancers in the context of Lynch syndrome through InSituPlex technology and Tissue Phenomics integration
FixVUE, InSituPlex
Learn more
poster
Use of Ultivue InSituPlex®Multiplex Immunofluorescence to Localize and Quantify Regulatory T Lymphocytes in Crohn’s Disease and Ulcerative Colitis
Collaboration, FixVUE, InSituPlex
Learn more
webinar
Spatially defining the future of cancer biology with advanced multiplexed immunofluorescence
Troy Bloom
30 minutes
InSituPlex
Learn more
webinar
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Jennifer Giltnane MD, PhD
Length: 46 minutes
FixVUE, InSituPlex





